MIPL-Logo

 

MIRA INFORM REPORT

 

 

Report No. :

332643

Report Date :

18.07.2015

 

IDENTIFICATION DETAILS

 

Name :

LEE PHARMA LIMITED

 

 

Formerly Known As :

LEE PHARMA PRIVATE LIMITED

 

 

Registered Office :

Survey No. 257 and 258/1, Door No.11-6/56, C Block, Opposite IDPL Factory, Moosapet (Village), Balanagar (Post), Hyderabad – 500037, Telangana

Tel. No.:

91-40-66170334

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

06.10.1997

 

 

Com. Reg. No.:

028095

 

 

Capital Investment / Paid-up Capital :

Rs. 14.509 Million

 

 

CIN No.:

[Company Identification No.]

U24230TG1997PLC028095

 

 

IEC No.:

0997005831

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACL3435F

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Bulk Drugs and Intermediates.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 1400000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Exist

 

 

Comments :

Subject was incorporated in October 1997, promoted by Mr. A Venkata Reddy and Mrs. A Ratna Kumari.

 

It is an established company having satisfactory track record.

 

Financial position of the company seems to be decent.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating = BBB-

Rating Explanation

Have moderate degree of safety and carry moderate credit risk.

Date

September 30, 2014

 

 

Rating Agency Name

CRISIL

Rating

Short term rating = A3

Rating Explanation

Have moderate degree of safety and carry higher credit risk.

Date

September 30, 2014

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE

 

(CONTACT NO.: 91-40-66170334)

 

 

LOCATIONS

 

Registered Office :

Survey No. 257 and 258/1, Door No.11-6/56, C Block, Opposite IDPL Factory, Moosapet (Village), Balanagar (Post), Hyderabad – 500037, Telangana, India

Tel. No.:

91-40-66170334/ 66170336

Fax No.:

91-40-66170330

E-Mail :

accounts@leepharma.com

info@leepharma.com

sales@leepharma.com

purchase@leepharma.com

Website :

http://www.leepharma.com

 

 

Factories :

Located at:

 

·         Hyderabad [2 units]

·         Visakhapatnam

 

 

DIRECTORS

 

AS ON 27.09.2014

 

Name :

Venkata Reddy Alla

Designation :

Managing director

Address :

Plot No. 157, Vivekananda Nagar Colony, Kukatpally, Hyderabad - 500072, Andhra Pradesh, India 

Date of Birth/Age :

15.02.1955

Qualification :

MA

Date of Appointment :

06.10.1997

PAN No.:

ABLPA4127G

DIN No.:

00018534

 

 

Name :

Ratna Kumari Alla

Designation :

Whole-time director

Address :

Plot No. 157, Vivekananda Nagar Colony, Kukatpally, Hyderabad - 500072, Andhra Pradesh, India 

Date of Birth/Age :

22.11.1960

Qualification :

B. Sc

Date of Appointment :

06.10.1997

PAN No.:

AAMPA7034L

DIN No.:

00022478

 

 

Name :

Dr Gopala Rao Tatineni

Designation :

Director

Address :

Flat No. 203, Siri Residency, Thakur Mansion Lane, Somajiguda, Hyderabad - 500072, Andhra Pradesh, India   

Date of Birth/Age :

15.07.1944

Date of Appointment :

22.04.1999

DIN No.:

00043939

 

 

Name :

Raghumitra Alla

Designation :

Whole-time director

Address :

Plot No. 157, Vivekananda Nagar Colony, Kukatpally, Hyderabad - 500072, Andhra Pradesh, India 

Date of Birth/Age :

10.10.1980

Qualification :

MS (USA)

Date of Appointment :

04.05.2006

PAN No.:

AIAPA2755N

DIN No.:

00080789

 

 

Name :

Mr. Vijaykumar Raghunandanprasad Agrawal

Designation :

Director

Address :

23, Ahoora Mahal, 6th Floor, 93, Marine Drive, G Road, Mumbai – 400002, Maharashtra, India

Date of Birth/Age :

13.03.1952

Date of Appointment :

27.09.2007

DIN No.:

01710632

 

 

Name :

Gary Ethan Kamins

Designation :

Director

Address :

1415, Via Cresta Pac Palisades Ca 90272, California USA 90272

Date of Birth/Age :

06.06.1962

Date of Appointment :

27.09.2007

DIN No.:

01832818

 

 

Name :

Francisco Javier Castellsague Casals

Designation :

Director

Address :

Grva Carlos III, 6131, Bareelona, Spain 08028

Date of Birth/Age :

09.06.1941

Date of Appointment :

27.09.2007

DIN No.:

01869905

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 27.09.2014

 

NOTE: SHAREHOLDING DETAILS FILE ATTACHED

 

 

AS ON 27.09.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

42.50

Directors or relatives of directors

57.50

 

 

Total

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs and Intermediates.

 

 

Products :

ITC Code No.

 

Product Descriptions

29349990

Itraconazole Pellets

29333999

Omeprazole

29333999

Omeprazole Pellets

29333999

Lansoprazole

29419090

Moxiflaxacin HCL

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Not Divulged

Countries :

Not Divulged

 

 

Imports :

 

Products :

Not Divulged

Countries :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

·         Dr. Reddy’s

·         Ranbaxy Laboratories Limited

·         Intas

·         Cadila Pharmaceuticals

·         Matrix

·         Aceto

·         Torrent

·         Denmark 

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

Bank Name:

Not Divulged

Branch:

Not Divulged

Person Name (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

·         State Bank of India

Balanagar Branch, Hyderabad - 500037, Andhra Pradesh, India

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term loans from banks

27.472

50.472

Term loans from others

8.648

6.005

Deferred payment liabilities

2.870

3.784

Loans and advances from related parties

13.318

9.050

Other loans and advances

56.381

1.053

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

450.706

377.880

Loans repayable on demand from others

34.833

0.000

 

 

 

Total

 

594.228

448.244

 

 

 

Auditors :

 

Name :

M V Narayana Reddy and Company

Chartered Accountants

Address :

504, Vijayasree Apartments, Opposite Kammasangam, Behind Chermas Ameerpet, Hyderabad – 500072, Andhra Pradesh, India

Income-tax PAN of auditor or auditor's firm :

AADFM4830F

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates :

·         Moehs Iberical S.A

·         Indkey Infra Projects Private Limited [U45201TG2007PTC056353]

·         Lee Health Domain India Private Limited [U65993TG1995PTC019971]

 

 

CAPITAL STRUCTURE

 

AFTER 27.09.2015

 

Authorised Capital : Rs. 76.500 Million

 

Issued, Subscribed & Paid-up Capital : Rs. 15.009 Million

 

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7,650,000

Equity Shares

Rs. 10/- each

Rs. 76.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,450,909

Equity Shares

Rs. 10/- each

Rs. 14.509 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

14.509

14.509

14.509

(b) Reserves & Surplus

487.170

440.269

385.440

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

501.679

454.778

399.949

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

126.377

99.084

41.514

(b) Deferred tax liabilities (Net)

63.878

41.547

37.411

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

5.155

5.288

5.656

Total Non-current Liabilities (3)

195.410

145.919

84.581

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

533.186

381.802

300.400

(b) Trade payables

591.784

482.838

335.636

(c) Other current liabilities

219.672

117.433

81.903

(d) Short-term provisions

17.710

12.901

7.511

Total Current Liabilities (4)

1362.352

994.974

725.450

 

 

 

 

TOTAL

2059.441

1595.671

1209.980

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

599.820

539.064

485.247

(ii) Intangible Assets

1.368

1.755

1.019

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

74.011

16.780

6.903

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

675.199

557.599

493.169

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

504.064

428.020

282.117

(c) Trade receivables

673.399

495.092

352.475

(d) Cash and cash equivalents

29.420

18.916

12.532

(e) Short-term loans and advances

143.903

75.751

69.582

(f) Other current assets

33.456

20.293

0.105

Total Current Assets

1384.242

1038.072

716.811

 

 

 

 

TOTAL

2059.441

1595.671

1209.980

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from Operations

2142.365

1606.324

1183.568

 

 

Other Income

0.000

16.175

23.623

 

 

TOTAL                                     (A)

2142.365

1622.499

1207.191

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1446.141

1171.471

813.569

 

 

Purchases of Stock-in-Trade

5.788

3.884

3.056

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

-96.603

-62.686

-4.029

 

 

Employees benefits expense

110.307

77.684

64.453

 

 

Other expenses

488.958

304.282

234.340

 

 

Prior Period Items

16.838

0.000

0.000

 

 

TOTAL                                     (B)

1971.429

1494.635

1111.389

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

170.936

127.864

95.802

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

62.548

46.194

37.675

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

108.388

81.670

58.127

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

38.811

32.129

28.687

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

69.577

49.541

29.440

 

 

 

 

 

Less

TAX                                                                  (H)

26.114

8.258

10.668

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

43.463

41.283

18.772

 

 

 

 

 

 

Earnings Per Share (Rs.)

29.96

28.45

12.94

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

45.475

27.038

15.999

 

 

 

 

Cash generated from operations

NA

NA

NA

 

 

 

 

Net cash flows from (used in) operations

(32.180)

(21.277)

(10.741)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

PAT / Total Income

(%)

2.03

2.57

1.59

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

7.98

7.96

8.09

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.38

3.10

2.43

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.14

0.11

0.07

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.41

1.12

0.89

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.02

1.04

0.99

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

14.509

14.509

14.509

Reserves & Surplus

385.440

440.269

487.170

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

399.949

454.778

501.679

 

 

 

 

Long-term borrowings

41.514

99.084

126.377

Short term borrowings

300.400

381.802

533.186

CURRENT MATURITIES OF LONG-TERM DEBTS

15.999

27.038

45.475

Total borrowings

357.913

507.924

705.038

Debt/Equity ratio

0.895

1.117

1.405

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1183.568

1606.324

2142.365

 

 

35.719

33.371

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1183.568

1606.324

2142.365

Profit

18.772

41.283

43.463

 

1.59%

2.57%

2.03%

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 


LITIGATION DETAILS

 

CEA 161 / 2010

CEASR 239 / 2010

CASE IS:PENDING

PETITIONER

 

RESPONDENT

THE COMMISSIONER OF CUSTOMS AND CENTRAL EXCISE

  VS

M/S LEE PHARMA PVT LTD.,

PET.ADV. : GOPALAKRISHNA GOKHALEY

 

RESP.ADV. : 

SUBJECT: PAYMENT OF DUTY TAX

 

DISTRICT:  HYDERABAD

FILING DATE:  20-01-2010

POSTING STAGE :  FOR ADMISSION

 

REG. DATE    :   18-05-2010

LISTING DATE :  05-07-2010

STATUS   :  ADMIT

HON'BLE JUDGE(S):

B.PRAKASH RAO    

RAMESH RANGANATHAN

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10546275

31/01/2015 *

641,200,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, MID CORPORATE GROUP, RAJBHAVAN ROAD, SOMAJIGUDA, HYDERABAD, TELANGANA - 500082, INDIA

C42975383

2

10522881

15/09/2014

14,012,020.00

ELECTRONICA FINANCE LIMITED

128/A, PLOT NO.3, KAILASHCHANDRA APPARTMENTS, PAUD ROAD, KOTHRUD, PUNE, MAHARASHTRA - 411038, INDIA

C23740855

3

10522893

25/07/2014

150,000,000.00

HDFC BANK LIMITED

1-10-60/3 4TH FLOOR SURYODAYA, BEGUMPET, HYDERABAD, TELANGANA - 500016, INDIA

C23775299

4

10497113

30/05/2014

5,272,591.00

RELIANCE CAPITAL LTD

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE CITY, KOPARKHAIRNE, NAVI MUMBAI, MAHARASHTRA - 400710, INDIA

C05346085

5

10475487

30/01/2014

100,000,000.00

SBI GLOBAL FACTORS LIMITED

6TH FLOOR, METROPOLITAN BUILDING, BANDRA-KURLA, COMPLEX, BANDRA(EAST), MUMBAI, MAHARASHTRA - 400051, INDIA

B95451597

6

10461134

22/11/2013

5,700,000.00

RELIANCE CAPITAL LIMITED

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE CITY, KOPARKHAIRNE, NAVI MUMBAI, MAHARASHTRA - 400710, INDIA

B89920805

7

10439220

30/06/2013

5,599,526.00

RELIANCE CAPITAL LIMITED

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE C 
ITY, KOPARKHAIRNE, NAVI MUMBAI, MAHARASHTRA - 4007 
10, INDIA

B80512213

8

10406787

26/02/2013

5,700,000.00

RELIANCE CAPITAL LIMITED

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE CITY, KOPARKHAIRNE, NAVI MUMBAI, MAHARASHTRA - 400710, INDIA

B69096345

9

10362105

30/04/2012

4,312,054.00

RELIANCE CAPITAL LIMITED

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE CITY, KOPARKHAIRNE, NAVI MUMBAI, MAHARASHTRA - 400710, INDIA

B42223701

10

90124067

19/12/2013 *

756,200,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, RAJ BHAVAN ROAD, SOMAJIGUDA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

B94460102

11

90258475

18/10/2005 *

5,200,000.00

STATE BANK OF INDIA

BALANAGAR BRANCH, HYDERABAD, ANDHRA PRADESH, INDIA

-

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Deposits

17.688

28.720

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

35.983

0.000

Loans repayable on demand from others

11.664

3.922

 

 

 

Total

 

65.335

32.642

 

 

CHANGE OF ADDRESS:

 

The Registered Office of the company has been shifted from Flat No 401, A Block, Saidatta Apartments, Srinivasa Nagar Colony (East), Ameerpet, Hyderabad - 500038, Andhra Pradesh, India to the present address w.e.f.09.05.2007.

 

 

REVIEW OF THE BUSINESS OPERATIONS

 

During the year, the Company has clocked a Total Income of Rs. 2142.365 Million as against Rs.1622.499 Million in the preceding financial year registering a growth of 32.04 % in the current year sales. The company has earned profit before tax of Rs. 69.577 Million (previous year Rs.49.54 Million) and provided for taxes of Rs.26.114 Million as against Rs.8.258 Million in previous year.

 

During the year the company has obtained CEP approvals for some of its products in European Markets. The Company's API Plant located at Khazipally got approval of US FDA in the month of June 2014. The Directors are optimistic in penetrating new markets in US and Europe and achieving higher exports and better results in the current year.

 

The company is also focusing in the domestic market to enhance its presence. This is because the company has been able to get into new segment molecules. At present the Company is supplying its APIs to major Formulators including Sun Pharma, Dr. Reddy's, Apotex, etc., in Indian Market. With the approval of US FDA for its API plant, the Directors are confident of broadening the customer base in the Domestic Market.

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Plant and equipment

·         Other plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Office equipment

·         Computer equipments

·         Other equipments

·         Computer software

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 63.49

UK Pound

1

Rs. 99.43

Euro

1

Rs. 69.14

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.